Drugs that bind to and activate the receptors for the hormones GLP-1 and GIP are effective in the treatment of obesity and diabetes. Surprisingly, active substances are currently being developed that ...

"The SMART 2.0 study proposal represents a significant step forward for the advancement of breast cancer prevention," said Steven C. Quay, CEO of Atossa Therapeutics. "By targeting mammographic ...

A new study reveals that cinnamon, a popular spice, may reduce the effectiveness of certain medications by activating ...

A Ludwig Cancer Research study has identified a specific mode of fat uptake by immune cells within tumors that serves as a ...

People taking GLP-1 receptor agonists appeared to be at elevated risk of rejection episodes after lung transplantation, a ...